Trial · NCT02573259
Adverse events2,520
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 2,520
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Atrial fibrillation | Cardiac disorders | Part 1: PF-06801591 0.5 mg/kg (Intravenously [IV]) | 0 | 2 | |
| other | Atrial fibrillation | Cardiac disorders | Part 1: PF-06801591 1 mg/kg (IV) | 1 | 8 | |
| other | Atrial fibrillation | Cardiac disorders | Part 1: PF-06801591 3 mg/kg (IV) | 0 | 8 | |
| other | Atrial fibrillation | Cardiac disorders | Part 1: PF-06801591 10 mg/kg (IV) | 0 | 7 | |
| other | Atrial fibrillation | Cardiac disorders | Part 1: PF-06801591 300 mg (Subcutaneously [SC]) | 0 | 15 | |
| other | Atrial fibrillation | Cardiac disorders | Part 1: PF-06801591 IV Total | 1 | 25 | |
| other | Atrial fibrillation | Cardiac disorders | Part 1: PF-06801591 IV and SC Total | 1 | 40 | |
| other | Atrial fibrillation | Cardiac disorders | Part 2: PF-06801591 300 mg (SC) for NSCLC | 3 | 68 | |
| other | Atrial fibrillation | Cardiac disorders | Part 2: PF-06801591 300 mg (SC) for UC | 0 | 38 | |
| other | Atrial fibrillation | Cardiac disorders | Part 2: PF-06801591 NSCLC and UC Total | 3 | 106 | |
| other | Bundle branch block | Cardiac disorders | Part 1: PF-06801591 0.5 mg/kg (Intravenously [IV]) | 0 | 2 | |
| other | Bundle branch block | Cardiac disorders | Part 1: PF-06801591 1 mg/kg (IV) | 0 | 8 | |
| other | Bundle branch block | Cardiac disorders | Part 1: PF-06801591 3 mg/kg (IV) | 1 | 8 | |
| other | Bundle branch block | Cardiac disorders | Part 1: PF-06801591 10 mg/kg (IV) | 0 | 7 | |
| other | Bundle branch block | Cardiac disorders | Part 1: PF-06801591 300 mg (Subcutaneously [SC]) | 0 | 15 | |
| other | Bundle branch block | Cardiac disorders | Part 1: PF-06801591 IV Total | 1 | 25 | |
| other | Bundle branch block | Cardiac disorders | Part 1: PF-06801591 IV and SC Total | 1 | 40 | |
| other | Bundle branch block | Cardiac disorders | Part 2: PF-06801591 300 mg (SC) for NSCLC | 0 | 68 | |
| other | Bundle branch block | Cardiac disorders | Part 2: PF-06801591 300 mg (SC) for UC | 0 | 38 | |
| other | Bundle branch block | Cardiac disorders | Part 2: PF-06801591 NSCLC and UC Total | 0 | 106 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02573259/events